Introduces the 5L DynaDrive Single-Use Bioreactor to Simplify and Accelerate Process Development
Exhibitor: THERMO FISHER SCIENTIFIC
Date: 2025-06-12
Booth No.: L330
Thermo Fisher Scientific Introduces the 5L DynaDrive Single-Use Bioreactor to Simplify and Accelerate Process Development and Help Bring Therapies to Market Faster
First-of-its-kind bench scale bioreactor enabling productivity, scalability and efficiency supporting reduced environmental impact
WALTHAM, Mass., April 14, 2025 – Thermo Fisher Scientific Inc., the world leader in serving science, today announced the 5L DynaDrive Single-Use Bioreactor (S.U.B.), designed to meet the evolving needs of modern bioprocessing. The 5L DynaDrive expands the company's robust portfolio of bioreactors, offering seamless scalability from 1 to 5,000 liters and accelerating bench-scale process development, while facilitating the cost-effective transition from bench to commercialization with consistent reactor design and film across all scales.
"The introduction of the 5L DynaDrive marks a significant advancement in our commitment to helping customers maximize productivity and accelerate time to market," said Ray Mercier, president of Thermo Fisher’s single-use technologies business. "With 25 years of experience in single-use technology, we are dedicated to meeting our customers' evolving needs. Our trusted innovations provide seamless scalability and enhanced efficiency, enabling customers to streamline their bioprocessing workflows and successfully develop and commercialize life-saving therapies."
The 5L DynaDrive single-use bioreactor is engineered to meet the diverse needs of large biopharma, Contract Development and Manufacturing Organizations (CDMOs), and small biotech companies. Its user-friendly design and benchtop size enables use with the HyPerforma™ G3Lab Controller to provide exceptional scalability and scalable proof of concept, affordably. With a 27% increase in productivity compared to glass bioreactors, the 5L DynaDrive combines small size with high performance and offers effective scale-up with consistent design, software, and film across all sizes. The robust, reliable solution utilizes biobased films built on Thermo Fisher’s existing Aegis™ film offerings and BioTitan Retention Devices, enabling minimized product loss and more sustainability.
To learn more about Thermo Fisher’s DynaDrive portfolio, please visit www.thermofisher.com/dynadrive.
More Exhibitor's Press Release
- One Platform for All Your Drug Discovery Insights. Book a meeting with us! CAS, A DIVISION OF THE AMERICAN CHEMICAL SOCIETY / 2025-06-13
- Japanese Experts Ryuji Kato and Masahiro Kino-oka to Present on QbD, PAT, and Automation in Cell Man PURPLE WIN INTERATIONAL LIMITED. / 2025-06-12
- PurpleWin Promotes BioLife’s Virus-Reduced hPL to Help Cell Therapy Developers Meet Regulatory Deman PURPLE WIN INTERATIONAL LIMITED. / 2025-06-12
- NanoDrop Ultra Microvolume UV-Vis Spectrophotometers J & H TECHNOLOGY CO., LTD. / 2025-06-12
- iAN®, an Ultra Rapid Microbiological Method J & H TECHNOLOGY CO., LTD. / 2025-06-12
- IOT無線連續監測系統 - 廠房、倉儲、實驗室 溫、濕度測繪 XIN TOP CORPORATION / 2025-06-11
- Taiwan’s Gene Therapy Pioneer Dr. Wuh-Liang Hwu Partners with TFBS Bioscience to Advance Gene Therap TFBS BIOSCIENCE, INC. / 2025-06-11
- Professional animal experimental service is your best choice for drug testing TAIWAN MOUSE CLINIC AND ANIMAL CONSORTIUM-NATIONAL COMPREHENSIVE MOUSE PHENOTYPING AND DRUG TESTING CENTER / 2025-06-11
- The Best Choice for Drug Testing and Preclinical Validation TAIWAN MOUSE CLINIC AND ANIMAL CONSORTIUM-NATIONAL COMPREHENSIVE MOUSE PHENOTYPING AND DRUG TESTING CENTER / 2025-06-11
- From Sample to Solution: AllisWell Bio Powers Your Cell Workflow ALLISWELL BIO CO., LTD. / 2025-06-09
- AllisWell Bio Builds the Future of Drug Screening with Integrated 3D Cell Culture and Bioprinting ALLISWELL BIO CO., LTD. / 2025-06-09
- Why choose Mecademic for robotic lab automation? JYTC CO., LTD. / 2025-06-07
- WCC Pioneering the Future of Microneedles WCC BIOMEDICAL CO., LTD. / 2025-06-06
- CMAC Amorphous Materials Case Study for Amorphous Pharmaceuticals Application EUFLEX TECHNOLOGY CORP. / 2025-06-04
- Fujifilm Rebrands Life Sciences Companies to Strengthen Position as Strategic Partners for Life FUJIFILM CORPORATION / 2025-06-04
- FUJIFILM Diosynth Biotechnologies and Regeneron Sign a 10-year U.S. Manufacturing Agreement FUJIFILM CORPORATION / 2025-06-04
- Empowering Taiwan’s Regenerative Medicine: AllisWell Bio Brings in ROHTO’s R:STEM Medium ALLISWELL BIO CO., LTD. / 2025-06-04
- Cell-Bio Biotechnology to Showcase Cutting-Edge Cell Analysis "Arsenal" and Launch CRO Services at B CELL-BIO BIOTECHNOLOGY CO., LTD. / 2025-06-04
- WCC Honored to Be Invited to the U.S. BARDA’s Exclusive Vaccine Innovation Forum WCC BIOMEDICAL CO., LTD. / 2025-06-04
- Cell Therapy's "Arms Dealer": Cell-Bio – A Witness to the Evolution of Taiwan's Cell Industry CELL-BIO BIOTECHNOLOGY CO., LTD. / 2025-06-03